FMP
NASDAQ
2.11 USD
0.0311 (1.47%)
Dr. Klaus Paulini Ph.D.
Healthcare
Biotechnology
https://www.zentaris.com
NASDAQ
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercializ...
0001113423
CA0079755017
007975402
315 Sigma Drive
843 900 3223
US
12
May 10, 2000
0001113423
NASDAQ
Biotechnology
Healthcare
007975402
CA0079755017
US
2.11
2.02
16.66k
10.25M
-
1.36-3.38
-1.95
-
-
-
-
-0.44
-
https://www.zentaris.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.